Oakworth Capital’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $73K | Sell |
164
-3
| -2% | -$1.34K | ﹤0.01% | 328 |
|
|
2025
Q1 | $81K | Hold |
167
| – | – | 0.01% | 318 |
|
|
2024
Q4 | $67.3K | Hold |
167
| – | – | ﹤0.01% | 333 |
|
|
2024
Q3 | $77.7K | Buy |
167
+25
| +18% | +$11.6K | 0.01% | 319 |
|
|
2024
Q2 | $66.6K | Buy |
+142
| New | +$66.6K | ﹤0.01% | 310 |
|
|
2023
Q2 | – | Sell |
-38
| Closed | -$12K | – | 653 |
|
|
2023
Q1 | $12K | Hold |
38
| – | – | ﹤0.01% | 419 |
|
|
2022
Q4 | $11K | Hold |
38
| – | – | ﹤0.01% | 412 |
|
|
2022
Q3 | $11K | Hold |
38
| – | – | ﹤0.01% | 436 |
|
|
2022
Q2 | $11K | Hold |
38
| – | – | ﹤0.01% | 439 |
|
|
2022
Q1 | $10K | Hold |
38
| – | – | ﹤0.01% | 453 |
|
|
2021
Q4 | $8K | Hold |
38
| – | – | ﹤0.01% | 507 |
|
|
2021
Q3 | $7K | Hold |
38
| – | – | ﹤0.01% | 502 |
|
|
2021
Q2 | $8K | Buy |
+38
| New | +$8K | ﹤0.01% | 492 |
|
|
2020
Q3 | – | Sell |
-14
| Closed | -$4K | – | 619 |
|
|
2020
Q2 | $4K | Buy |
+14
| New | +$4K | ﹤0.01% | 499 |
|